atomoxetine hydrochloride has been researched along with Aprosodia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khaletskaia, OV; Lar'kina, EV | 1 |
| Al-Alami, AA | 1 |
1 trial(s) available for atomoxetine hydrochloride and Aprosodia
| Article | Year |
|---|---|
[Tactics of management of preschool children with different variants of speech delay].
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Child; Child, Preschool; Female; Humans; Intercellular Signaling Peptides and Proteins; Language Development Disorders; Male; Nootropic Agents; Peptides; Piracetam; Propylamines; Speech Disorders; Treatment Outcome | 2014 |
1 other study(ies) available for atomoxetine hydrochloride and Aprosodia
| Article | Year |
|---|---|
Successful treatment of early ropivacaine toxicity with intralipid in a patient with attention deficit hyperactivity disorder.
Topics: Adolescent; Amides; Anesthesia, General; Anesthetics, Local; Arthroscopy; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Confusion; Emulsions; Hallucinations; Humans; Hypnotics and Sedatives; Intraoperative Complications; Male; Midazolam; Nerve Block; Phospholipids; Propylamines; Ropivacaine; Shoulder; Soybean Oil; Speech Disorders | 2011 |